$DLB

Dolby Laboratories (NYSE:DLB) Misses Q2 CY2026 Sales Expectations

Audio and video technology company Dolby Laboratories (NYSE: DLB) missed Wall Street’s revenue expectations in Q2 CY2026, with sales falling 3.3% year on year to $305 million. On the other hand, next quarter’s outlook exceeded expectations with revenue guided to $377 million at the midpoint, or 7.4% above analysts’ estimates. Its non-GAAP profit of $0.69 per share was 3% above analysts’ consensus estimates. Is now the time to buy Dolby Laboratories?

Original reporting
Published Jul 30, 2026, 10:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 10:24 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Dolby Laboratories (NYSE:DLB) Misses Q2 CY2026 Sales Expectations — source image
Decision brief

The 30-second read

$DLBNeutralMed
01

Why it matters

Traders may reprice near-term expectations based on the next-quarter revenue midpoint beat, while monitoring whether the Q2 miss and negative CAC payback persist.

02

Market read

A Q2 revenue miss is offset by above-consensus next-quarter revenue guidance, creating a mixed catalyst for DLB positioning.

03

What to watch

The article notes non-GAAP EPS of $0.69 was above consensus, and CAC payback was negative, which could matter for longer-term margin and growth quality beyond the headline revenue miss.

Relevance 7/10Novelty 6/10Timing: post-Q2 results, next-quarter guidance focus

Background

Dolby is an audio and video technology licensor, and the article frames the quarter around revenue performance, guidance, and customer acquisition efficiency.

Company-level read

Ticker impact

$DLBNeutralMedium confidence
Context

Dolby missed Q2 CY2026 revenue expectations, with sales down 3.3% YoY to $305M, while guiding next-quarter revenue to $377M midpoint.

Expected impact

Choppy trading likely, with downside risk from the Q2 miss offset by upside bias from the stronger next-quarter revenue outlook.

Evidence & confidence

The article provides both a negative datapoint (Q2 revenue decline and miss) and a positive datapoint (next-quarter revenue guidance 7.4% above estimates), which typically drives short-term volatility rather than a one-direction repricing.

Market effects

Signals demand and monetization pressure in audio-video licensing, but forward revenue guide suggests pockets of resilience.

No specific regional spillover described.

No explicit global macro or international regulatory drivers mentioned.

Counterpoint

The Q2 revenue decline could reflect timing or one-off softness, and the beat in next-quarter guidance may indicate improving demand rather than structural deterioration.

Key entities

  • Dolby Laboratories

    Audio and video technology company reporting Q2 CY2026 sales down 3.3% YoY and providing next-quarter revenue guidance.

  • Kevin Yeaman

    CEO and President quoted saying the company is executing full-year objectives and building momentum in growth areas.

Related articles

$DLBMed

Dolby Laboratories, Inc. Q3 2026 Earnings Call Summary

Dolby Laboratories’ Q3 2026 earnings call said it is shifting toward content platforms and usage-based revenue, targeting 10% of total revenue from partners by FY2028. Management cited traction for its Video Distribution Program, including Meta and Alibaba deals, and a China-first automotive strategy. Q4 guidance calls for 23% YoY revenue growth, with a $4M restructuring charge and a $350M share repurchase authorization increase.

$DLBMed

Why Dolby Labs Stock Popped Today

Dolby Laboratories (NYSE: DLB) shares rose 11.7% by 10:45 a.m. ET after its fiscal Q3 2026 results. The company reported revenue of $305 million versus an estimated $312 million, and EPS of $0.69 versus $0.67 expected. GAAP EPS was $0.30. Dolby guided Q4 sales to $362 million-$392 million and full-year revenue to at least $1.4 billion.

$DLBMedAI 8/10

Dolby (DLB) Q3 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Peter L. Goldmacher Chief Executive Officer - Kevin J. Yeaman Chief Financial Officer - Robert J. Park TAKEAWAYS Revenue -- $305 million, falling within management guidance ranges despite timing-related impacts in foundational audio. Non-GAAP EPS -- $0.69, exceeding the midpoint of guidance as lower operating expenses helped offset revenue shifts.

$DLBHighAI 9/10

Dolby Laboratories Reports Third Quarter 2026 Financial Results

Copyright 2026 PR Newswire. All Rights Reserved 2026-07-30 SAN FRANCISCO, July 30, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the third quarter of fiscal 2026. "We continue to execute against our full-year objectives, and we are building momentum across several of our key growth areas," said Kevin Yeaman, President and CEO, Dolby Laboratories.

$DLBHigh

Dolby Laboratories, Inc. (DLB): Results of Operations and Financial Condition

Dolby Laboratories, Inc. (DLB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d165402dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Dolby Laboratories Reports Third Quarter 2026 Financial Results SAN FRANCISCO, July 30, 2026 — Dolby Laboratories, Inc. (NYSE:DLB) today announced the company’s financial results for the third quarter of fiscal 2026. “We co

$DTMedAI 8/10

Dynatrace Springs on Q1 Figures

Dynatrace (NYSE: DT) reported Q1 FY2027 results for the quarter ended June 30, 2026. Total ARR was $2,136 million, up 17%. Total revenue rose to $555 million, up 16%. Subscription revenue was $530 million. GAAP operating income was $71 million and non-GAAP $162 million. CEO Rick McConnell cited 41% organic net new ARR growth and accelerating TTM growth.